The annual domestic use of pesticides is continually increasing, virtually ensuring that everyone is exposed to some level of pesticides on a regular basis through diet or environment. The potential developmental and physical adverse effects these chronic pesticide exposures have on children are of increasing concern. To adequately evaluate the potential adverse effects resulting from these exposures, accurate methods to measure the amount of the pesticide absorbed by the body must be developed. We have developed a sensitive method to measure the urinary metabolites of atrazine, diazinon, malathion, 2,4 -dichlorophenoxyacetic acid ( 2,4 -D ) , and certain synthetic pyrethroids in human urine. In our method, stable isotopically labeled analogues of the metabolites were spiked into the urine, which was subsequently extracted at both a neutral and acidic pH using organic solvents. The extracts were analyzed by highperformance liquid chromatography coupled with tandem mass spectrometry ( HPLC -MS / MS ) using atmospheric pressure chemical ionization. Our method has limits of detection ranging from 20 to 500 ng / l ( parts per trillion ) and relative standard deviations of less than 11%. This method has been used to measure the internal doses of these pesticides in both adults and children ( n = 130 ) with no documented exposure to the pesticides. We detected atrazine and synthetic pyrethroid metabolites in less than 12% of the samples analyzed. The metabolites of 2,4 -D, malathion, and diazinon were detected in 22%, 32%, and 57% of the samples, respectively. Journal of Exposure Analysis and Environmental Epidemiology ( 2000 ) 10, 789 ± 798.
Introduction
The annual domestic use of pesticides is an estimated 3 to 5 billion pounds (EPA, 1997) . This figure includes both conventional and nonconventional pesticides such as herbicides, insecticides, and fungicides that are applied in both agricultural and residential settings. Their extensive and widespread use make it virtually impossible for anyone to completely avoid exposure. In fact, most individuals in the U.S. receive repeated low-dose exposures to pesticides. Although the toxic effects of acute exposure to pesticides on human health are well studied, information on adverse health outcomes associated with chronic low -dose exposure is lacking.
Recently, a great deal of attention has been focused on chronic pesticide exposure in vulnerable populations such as children (Davis and Ahmed, 1998; Dreary et al., 1999; Eskenazi et al., 1999; Landrigan et al., 1999 ) . These studies and others currently being conducted are beginning to address the consequences of chronic pesticide exposure in children. To accurately conduct these important studies, a good measure of individual exposure Ð or more importantly, a measure of the actual amount of pesticide that enters the body or the internal dose Ð to a variety of popular pesticides is needed. Biological monitoring of exposure by measuring the pesticide and /or its metabolite in biological matrices, such as urine, provides a quantitative measure of the individual internal dose.
Unfortunately, few analytical methods for measuring the internal dose include multiple pesticides, and most deal only with one class of pesticides, such as organophosphates or pyrethroids. We previously reported a sensitive and selective method for measuring the structurally diverse urinary metabolites of three prevalently used pesticides Ð atrazine, malathion, and 2,4-dichlorophenoxyacetic acid (2,4 -D ) (as either its salt or ester ) (Beeson et al., 1999 ) . Their metabolites are atrazine mercapturate (ATZ; Figure 1A ), malathion diacid (MDA; Figure 1B ) , and 2,4 -D ( Figure  1C ), respectively. We have modified this method to include two additional metabolites, 2-isopropyl -4 -methyl -6 -hydroxypyrimidine (IMPY; Figure 1D ), which is a metabolite of the organophosphate diazinon, and 3 -phenoxybenzoic acid (3PBA; Figure 1E ) , a common metabolite of several synthetic pyrethroids such as permethrin.
Methods for analyzing urine for these metabolites, with the exception of IMPY, have been reported in the literature. Without exception, these analyses measure only a single metabolite or a few metabolites in a single pesticide class and usually lack selectivity and/ or sensitivity. Analytical methods for measuring ATZ include liquid scintillation counting, high -performance liquid chromatography with UV detection (HPLC -UV ), gas chromatography with nitrogen ± phosphorous detection (GC -NPD ), and accelerator mass spectrometry (MS ) ( Gilman et al., 1998; Ikonen et al., 1988 ) . Both HPLC -UV and GC -NPD lack the selectivity of MS -based methods and usually are not sensitive enough to detect trace levels of metabolites. Both liquid scintillation counting and accelerator MS are sensitive, but require specialized equipment or radioactive isotopes not generally available.
Both MDA and 2,4 -D have been analyzed using GC with electron -capture detection (GC -ECD ), NPD or GC -MS (Bradway and Shafik, 1977; Fenske and Leffingwell, 1989; Draper et al., 1991; Hill et al., 1995a; Aprea et al., 1997a ) . These methods require a derivatization step that can be time -consuming and often requires additional cleanup steps to improve sensitivity.
Several methods have been reported for the analysis of 3PBA in urine. These methods all employ chemical derivatization of 3PBA followed by analysis using GC -ECD ( Aprea et al., 1997b ) or GC -MS Leng et al., 1996 Leng et al., , 1997 Anger and Ritter, 1997 ) . These methods are sensitive, somewhat selective, and use instrumentation that is commonly available. However, by adding an additional stage of MS, greater selectivity can be obtained.
There are no reported methods for the measurement of IMPY in non-occupationally exposed individuals. Only one published report mentions the detection of IMPY in 24 -h urine samples collected from occupationally exposed persons (Kawai et al., 1986 ) . This paper describes our method for measuring the urinary metabolites of the pesticides atrazine, malathion, 2,4 -D or its esters or salts, diazinon, and common synthetic pyrethroids. More specifically, we describe our method for measuring ATZ, MDA, 3PBA, IMPY, and 2,4 -D in human urine using the isotope-dilution technique combined with high -performance liquid chromatography / tandem mass spectrometry ( HPLC -MS /MS ).
Materials and methods

Materials
All solvents were analytical grade and were purchased from Caledon Laboratories LTD. (Georgetown, Ont., Canada ) or Burdick and Jackson Co. (Muskegon, MI ). 2,4-D (98% purity ) was purchased from Sigma Chemical Co. (St. Louis, MO ). 3 -PBA (99.5% purity) was purchased from Dr. Ehrenstorfer GmbH ( EQ, Augsberg, Germany ). IMPY (Ciba Geigy; 99% purity after recrystallization ) was synthesized in house. Dr. Bruce Hammock at the University of California ( Davis ) graciously provided the ATZ (97% purity ), and the U.S. Environmental Protection Agency Pesticide Repository (Research Triangle Park, NC ) supplied the malathion dicarboxylic acid ( 88.3% purity ). Ring -13 C 6 -2,4 -D ( 99% isotopic purity ), ring -13 C 6 -ATZ (99% isotopic purity ), phenyl -13 C 6 -labeled 3PBA (99% 
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Pesticide metabolites in human urine isotopic purity ) , and methyl -4,5,6 -13 C 4 -IMPY (99% isotopic purity ) were purchased from Cambridge Isotope Labs, Inc. (Andover, MA ) . D 7 -labeled malathion dicarboxylic acid (97% isotopic purity ) was provided by the State of California Department of Health Services.
Gases used by the instrumentation had a minimum purity of 99.999% and were purchased from Holox (Atlanta, GA ) or Linde, Union Carbide Corporation ( New York, NY ). Reagents were prepared using deionized water, which was organically and biologically purified with a model 2002BLU type I reagent -grade water purification system ( Solution Consultants, Inc., Jasper, GA ).
Standard preparation
Internal Standard Spiking Solution An internal standard spiking solution was prepared by weighing approximately 1.00 mg ( 0.02 mg ) of each isotopically labeled analyte into a 100-ml volumetric flask and dissolving with acetonitrile. The resultant 10 ng / l solution was divided into 1 -ml aliquots, placed in glass ampules, flame sealed and stored at À 208C. This spiking solution was used as an internal standard in all unknown samples, quality control (QC ) materials and calibration standards.
Native Standard Spiking Solution A native ( i.e., not isotopically labeled) standard stock solution was prepared by individually weighing 1 mg of each analyte and dissolving the combined portions in 1 ml acetonitrile. A set of nine standard spiking solutions with varying concentrations was prepared from the stock solution by diluting with acetonitrile. When 100 l were spiked into 10 ml of urine, the standards had concentrations of 0.1, 0.2, 0.5, 1, 2.5, 5, 10, 25, and 50 g/l. The standard spiking solutions were stored in sealed ampules at À 208C. The spiking solutions were used exclusively for the preparation of calibration standards.
Calibration Standards
Calibration standards were prepared daily by spiking 10 ml of``blank'' urine with 25 l of the internal standard spiking solution and 100 l of the appropriate native standard spiking solution. The urine was prepared according to the extraction procedure, described below, which was performed on unknown samples and quality control materials.
Quality control materials
Urine was collected from multiple ( > 30 ) donors, combined, diluted with water (1:1 v/ v) to reduce endogenous levels of the analytes of interest, and mixed overnight at 208C. After pressure filtering with a 0.2 -m filter capsule, the urine was divided into three pools. The first pool ( low pool ) was spiked with the native standard stock solution to yield an approximate concentration of 8 g/ l. The second pool (high pool ) was spiked with the native standard stock solution to yield an approximate concentration of 20 g/l. The third pool was not spiked. After being screened for possible endogenous analytes, it was used as matrix material for calibration standards and blanks.
All QC pools were characterized to determine the mean and 99th and 95th control limits by consecutively analyzing at least 20 samples from each QC pool. A run was considered``out -of -control'' if the QC for a run was outside the 99th percentile or if the QC from the second of two consecutive runs was also outside of the 95th percentile. Unknown samples in a run deemed out -of -control were reanalyzed.
Sample preparation
Our method is a modification of that reported by Beeson et al. (1999 ) . Urine (10 ml ) was pipetted into 50-ml screw -cap centrifuge tubes, spiked with 25 l of the internal standard spiking solution, and briefly vortexmixed. To free any glucuronide -bound IMPY or 3PBA, the samples were incubated for 17 h at 378C with 10 ml of a 0.1 M acetate buffer ( pH 4.5 ) solution containing 4290 units activity -glucuronidase and 245 units activity sulfatase (Sigma) . After incubation, approximately 200 l of 3 N NaOH was added to each sample to adjust the pH 6.5 0.5 ( measured with pH paper ). The pH -adjusted urine hydrolysates were extracted with 7.5 ml diethyl ether ±methylene chloride ( 4:1 ) by rotating the sample tubes for 8 min at 35 rpm to avoid emulsifying the samples. After centrifugation at 2000 rpm for 20 min, the organic layer ( top ) was transferred into a 15 -ml conical tube. The extraction was repeated and the extracts were combined. These combined extracts were used only for the analysis of 3PBA. In order to effectively extract the remaining analytes, the pH was adjusted to 3 0.5 by adding approximately 500 l 10% sulfuric acid. The acidic hydrolysate was extracted twice using the procedure described above and the extracts were combined into a clean 15 -ml conical tube. Therefore, for each urine sample, two separate extracts were obtained. The extracts were concentrated to 50 l each using a TurboVap LV Evaporator ( Zymark, Framingham, MA ) at 508C and using 10 psi of nitrogen. To adjust the extract solvent composition to one more compatible with the chromatographic system, 100 l of methanol was added to each extract and vortex mixed. The extracts were transferred to auto -injection vials which were loaded into the autosampler or refrigerated at 58C until analysis.
Instrumental analysis
The HPLC -MS /MS analysis was performed on an HP 1090 liquid chromatograph ( Hewlett Packard, Palo Alto, CA ) interfaced to a TSQ7000 triple quadrupole mass spectrometer (Finnigan MAT Instruments, San Jose, CA ). Chromatographic separation was performed on an Aquasil C 18 (5 m 100 A, 4.6 mmÂ100 ) column (Keystone Scientific, Inc., Bellefonte, PA ) . The mobile phases were mixtures of methanol and water acidified with 0.1% acetic acid at a flow rate of 1 ml /min. The initial mobile phase was 30% ( v/ v) methanol in water and was increased linearly to 100% methanol over 8.1 min. The column was equilibrated at initial mobile phase conditions for 2.9 min between injections. The analytes of interest eluted from the column between three and eight min. The MS was operated in the daughter ion mode using both positive and negative atmospheric pressure chemical ionization (APCI ) depending on the particular analyte ( Table 1 ). The heated capillary and vaporizer temperatures were 2258C and 4258C, respectively. The corona current was set at 5 A and the sheath gas pressure was 40 psi. The tube lens voltage was 85 V and the capillary voltage was 45 V; the polarity of the voltage changing with the polarity of ions being analyzed. Collision-induced dissociation ( CID ) was performed using argon at 2.5 mT. The collision offset voltages were optimized for each analyte ( Table 1 ) . The electron multiplier was set at 1800 V.
Data processing /analysis
Peaks were automatically integrated using QUAN (ICIS version 8.3.0 SP2 for OSF1 (V4.0 ) ) , the analysis software provided with the MS. Correct peak selection and accurate integration were checked by the analyst and any discrepancies were corrected. Peak areas, and other pertinent data, were then transferred via an ethernet connection to a PC for storage using R:BASE ( version 4.5+ ; Microrim, Redmond, WA ) and statistical analysis using SAS software (SAS Institute Inc., Cary, NC ) .
Quantification
Calibration curves were constructed with nine different analyte concentrations plotted against the response factors. Response factors were calculated as the area of the analyte quantification ion divided by the area of the labeled analyte ion. At least five repeat determinations were performed for each concentration on the calibration curve.
Calibration standard concentrations encompassed the entire linear range of the analysis. The lowest standard concentrations were at or below the LOD to ensure linearity and accuracy at the low concentration end. A linear regression analysis of the calibration plot provided a slope and intercept from which unknown sample concentrations could be determined. The y-intercept was not statistically different from zero unless a detectable amount of the analyte was endogenous in the``blank'' pooled urine.
Method validation
Glucuronide /Sulfate Conjugated IMPY Unknown urine samples were analyzed using the procedure described above. Those samples with measurable values of IMPY were reanalyzed except the enzyme hydrolysis procedure was omitted. The ratio of the calculated concentration without hydrolysis to that with hydrolysis was determined. The percentage of conjugation of IMPY in the urine was estimated to be the mean of the ratios.
Limits of Detection
The analytical limit of detection (LOD ) was calculated for each analyte as 3s 0 , where s 0 is the standard deviation at zero concentration. Where the``blank'' urine used for calibration samples contained an endogenous amount of the analyte, the LOD was three times the blank signal ( s 0 ) in concentration units. In every other instance, s 0 was estimated as the y -intercept of a linear regression analysis of a plot of the standard deviation (in units of concentration ) versus the concentrations of the four lowest standards (Taylor, 1987 ) .
Extraction Efficiency
The recovery of the method was determined at two concentrations (5 g/l and 50 g/ l) by spiking five ``blank'' urine samples with 100 l of the appropriate native standard spiking solution and extracting according to the method. Five additional``blank'' urine samples ( unspiked ) were extracted concurrently. Prior to the evaporation step, all the extracts were spiked with a known amount of the internal standard spiking solution to correct for instrument variation resulting in a more accurate recovery calculation. The samples that were not spiked prior to preparation were then spiked with 100 l of the appropriate native standard spiking solution to serve as control samples representative of 100% recovery. After evaporating and reconstituting, the samples were analyzed. The recovery was calculated by comparing the response of the native standard spiking solution to the response of the internal standard spiking solution.
Accuracy
The accuracy of the method was determined by spiking`b lank'' urine samples at different concentrations and calculating the concentrations using our method. A linear regression analysis was performed on a plot of the measured concentrations versus the expected concentrations. The slope of the resulting line was evaluated. A slope of 1.00 would indicate 100% accuracy. Additionally, the accuracy was determined at each of the concentration levels by comparing the measured concentrations with the expected concentrations. A ratio of 1.00 would indicate 100% accuracy.
Selectivity
There is currently no objective way of determining the degree of selectivity of an analytical method. However, as a matter of consensus, chromatographic separation coupled with tandem mass spectrometry is considered the most selective analytical technique available ( Persson et al., 1998 ) . Additionally, the use of the isotope dilution technique, which provides a chromatographic reference for peak selection, adds another degree of selectivity to the method. Apparent interferences in the form of extra chromatographic peaks or peak shoulders were rarely, if ever, encountered. Unknown interferences typically resulted in an increased background signal. These unknown interferences were only observed for 3PBA and were resolved by extraction at a neutral pH.
Precision
The method precision was determined by calculating the coefficient of variation (CV ) of repeat measurements of the quality control materials at two different concentrations ( about 8 g/ l and 20 g /l) . At least 50 repeat measurements over a 2-month period were used in the calculations. In addition, both interday and intraday variation were determined.
Sample Stability
The stability of the analytes measured in urine samples was determined by monitoring any degradation in their concentrations in the quality control pools, which were kept at the same temperature as unknown samples, over the course of the study. The stability of the sample extracts was determined in a similar manner.
Human studies
Our method was used to assess human exposure to atrazine, diazinon, malathion, certain synthetic pyrethroids, 2,4-D and its salts and esters. Urine samples (n = 130) were collected from adults and children with no known exposure to the pesticides studied. Samples were frozen within 4 h of collection and were stored at À 208C prior to analysis. All protocols were reviewed and approved by a human subjects review committee and complied with all institutional guidelines for the protection of human subjects.
Results and discussion
The parent pesticides or metabolites analyzed using this method are shown in Table 2 . These analytes were selected primarily based on the prevalence of their use and the compatibility of their analytical properties. Diazinon is the most widely used residential organophosphate pesticide (EPA, 1997 ) ; therefore, the potential for childhood exposure to it is high. Both diazinon and malathion are commonly used as agricultural insecticides on crops (including fruits, grains, vegetables, and herbs ) and in industrial settings ( EPA, 1997 ) . Atrazine is the most commonly used agricultural pesticide and 2,4 -D, and its esters and salts are the most commonly used residential pesticides ( EPA, 1997 ). 2,4 -D mixtures are available in most lawn and garden stores, and atrazine is commonly applied by commercial lawn pesticide services.
Because of the structural similarity of diazinon to other organophosphate insecticides, we assumed its metabolism would be similar to those that have been well studied in humans such as chlorpyrifos. Thus, we believed a certain percentage of IMPY would be excreted as its respective glucuronide and /or sulfate conjugate. To ascertain the approximate percentage and consistency of conjugation, we performed the experiment outlined above. Indeed, we found that the majority of IMPY was excreted in its conjugated form. On average, about 97% of the IMPY was conjugated, but it ranged from 67% to 100% depending on the sample. These data are shown in Figure 2 . The individual analyte recoveries of our extraction procedure are shown in Table 3 . The recoveries ranged from about 10% with IMPY to nearly quantitative recoveries for other analytes. We suspect that the low recovery of IMPY was due to the ionizable nitrogens in its heterocyclic ring. As the pH was reduced to ensure the hydroxyl group was not ionized, it is likely that one or both of the nitrogens may have been protonated making IMPY difficult to extract from an aqueous solution. Most analytes had equivalent or reduced recoveries at lower concentrations than at a higher concentration. Interestingly, however, 3PBA showed a dramatic and repeatable reduction in recovery at the higher concentration than at the lower concentration. Fortunately, this concentration -dependent variation in recovery can be automatically corrected by use of the isotope dilution technique. Using the isotope dilution technique, the individual recovery of each analyte in a sample is automatically corrected so variable extraction recoveries did not negatively affect the accuracy of the data obtained.
To maximize our method sensitivity, we evaluated not only the efficiency of the extraction procedure but also the relative amount of noise or interference generated by the coextracted analytes at varying pHs. Although the optimum pH of extraction with an organic solvent for these acidic analytes is about 3.5 as general chemistry principles would dictate, the LOD of 3PBA can be substantially reduced by extracting at a neutral pH. By extracting at a neutral pH, we drastically improved the signal to noise ratio of the 3PBA ion ( Figure 3) . We postulate that a neutral extraction reduces the noise by minimizing the extraction of ionizable interferents, thus reducing the coextractable analytes the mass spectrometer detects. Unfortunately, the addition of a second extraction step at a neutral pH was time -consuming. In addition, a separate injection was made to analyze 3PBA because combining the acidic extract with the neutral extract reintroduced the noise. However, the dramatic reduction of the LOD was worth the cost in time. None of the other analytes was significantly affected by the neutral extraction step.
The LODs of the method are shown in Table 3 . The LODs ranged from 0.20 to 0.50 g/ l. Interestingly, IMPY, the analyte with the most sensitivity was the most poorly recovered compound. This is due to the extremely sensitive on -column detectability of IMPY. Most probably, a nitrogen on the heterocyclic ring of IMPY is easily ionized thus increasing IMPY's overall ionization efficiency in the APCI source.
A typical mass chromatogram of a urine extract is shown in Figure 4 . The elution pattern shows that compounds Sensitivities of the analytes were greatly reduced when switching the mass spectrometer between ion polarities for each successive scan. Therefore, initially, distinct windows were defined to collect data for one particular ion polarity during a given retention time period. However, variations in the coextracted components among samples sometimes caused chromatographic shifts of analyte peaks outside of the specified retention windows resulting in lost data. Rather than sacrifice sensitivity or loss of data, we chose to analyze each acidic extract once in the positive ion mode and once in the negative ion mode. The neutral extract was only analyzed in the negative ion mode. Figure 5 shows a calibration curve for IMPY which is typical of the other analytes. Linear regression analyses of the plots produced R 2 values greater than 0.988 for all analytes with standard errors about the slopes of less than 2%. The calibration data and linear ranges of the method are listed in Table 4 .
A Shewart plot of analyses of quality control materials for IMPY is shown in Figure 6 . The other analytes produced similar plots. The relative standard deviation and the intraand interday variations of the method are shown in Table 3 . The precision at lower concentrations was similar to that at higher concentrations. In all cases, the total variation was less than 11%. Interestingly, the larger contributor to the variation was typically that obtained within a run. We have identified no clear explanation for this observation.
A plot of the expected concentration of IMPY versus the calculated concentration of IMPY is shown in Figure 7 . The correlation coefficient of the plot was 0.996 with a standard error about the slope of less than 2%.
The analytes were shown to be stable in diluted urine samples kept at À 208C. No degradation in the concentrations were observed over a 6 -month period. The dilution of the urine for preparation of the quality control pool did not alter the matrix effects of the urine; in fact, the urine was similar, in both physical appearance, creatinine concentration, and matrix effects to many of the spot urine samples obtained for health studies. Therefore, we infer that the analytes are stable in spot urine samples over the same time period. The stability of the analytes in urine at room temperature or under refrigeration has not been determined. However, the sample extracts were stable for at least 2 weeks at 48C. As previously reported ( Beeson et al., 1999 ) , our method is more selective and more sensitive than previously published methods for the measurement of 2,4-D, ATZ, and MDA. For 3PBA, our method has a similar detection limit (0.5 g /l) as other methods ( 0.5± 1 g /l) Leng et al., 1996; Anger and Ritter, 1997) ; however, our method is more selective by adding an additional stage of mass spectrometry. Additionally, our method does not require a derivatization step. To our knowledge, no other methods exist for the quantification of IMPY in urine. This is most likely due to the poor extraction recovery of IMPY which requires an extremely sensitive detection system for analysis. In many instances, use of HPLC interfaced to tandem mass spectrometry is cost prohibitive.
Our method has been used to measure the internal doses of diazinon, malathion, atrazine, certain synthetic pyrethroids, 2,4 -D, and its salts and esters in humans resulting from mostly incidental exposures. Consistent with our previous results, ATZ was detected in only 2% of the samples we analyzed at concentrations less than 1 g/g creatinine. MDA and 2,4 -D were detected in 32% (range ND to 65 g/ g creatinine ) and 22% ( range ND to 8 g/g creatinine ) of the samples, respectively. Both MDA and 2,4 -D were detected at lower frequencies than we have observed recently in our laboratory ( Beeson et al., 1999 ) . However, we detected concentrations in a much greater percentage of the samples than detected in the Second and Third National Health and Nutrition Examination Surveys for MDA ( 0.5% ) ( Kutz et al., 1992 ) and 2,4 -D ( 12% ) (Hill et al., 1995b ) . Surprisingly, 3PBA was detected in only 12% of the samples but at concentrations up to 30 g/g creatinine or 20 g/l in urine not corrected for dilution. Anger and Ritter (1997) reported 3PBA concentrations from occupationally exposed pest controllers that ranged from 2.5 to 43 g/g creatinine and Aprea et al. ( 1997b ) reported a similar range. Tuomainen et al. ( 1996 ) reported urinary 3PBA concentrations (range 2.4± 52 g/ l) in greenhouse workers exposed to deltamethrin. These occupationally derived 3PBA concentrations clearly overlapped with those concentrations we observed from incidental exposures suggesting that people residing or entering premises treated with pyrethroids may be exposed to similar concentrations of the pesticides as the applicators.
IMPY had the highest frequency of detection at 57% (range ND to 10 g /l) indicating that diazinon exposure is prevalent. Additionally, the IMPY data confirm that our method possesses adequate sensitivity to measure internal Concentration (ug/L) Linear range (ppb) doses resulting from low -level exposure to diazinon. To our knowledge, no other data from biological monitoring of exposure to IMPY have been reported. Although this method is reliable and robust and is suitable for measuring low -level internal doses, there are several apparent limitations of the method. The extraction procedure is both cumbersome and labor-intensive. Without dispute, the sample preparation procedure is the bottleneck of the method requiring a full 8-h day to process about 25 samples. Furthermore, the need to keep the various extracts separated is cumbersome and subject to errors in manipulation.
Although the LOD of ATZ is comparatively low, its poor extraction efficiency no doubt contributes to its low frequency of detection in our samples because we know it is prevalent in the environment. With an improvement in the extraction of ATZ, the LOD can be significantly lowered, therefore, increasing our probability of detecting its metabolite. A similar argument could be made for IMPY, although we detect it far more frequently. Unfortunately, the diverse structures of the analytes measured in this method require the use of a generalized extraction procedure. Our future plans include improving the extraction of these two analytes.
Conclusion
We have developed a method for the analysis of the metabolites of atrazine, malathion, diazinon, synthetic pyrethroids, and 2,4 -D and its salts and esters in urine using isotope dilution HPLC -MS /MS. Our method is sensitive, accurate, and precise. The low analytical LODs make this method suitable for the measurement of internal doses resulting from incidental, low-level exposures such as those commonly occurring with children. The robustness of the method has been demonstrated by the stability and precision of the measurement system over several months. This method is the first to measure the primary urinary metabolite of diazinon. Our human data confirm that this method possesses the needed sensitivity to measure internal doses resulting from incidental exposure to diazinon. In addition, our data confirm that exposure to diazinon is prevalent. This method can be used routinely for biological monitoring of exposure in laboratories with HPLC -MS /MS instruments and access to isotopically labeled standards.
